TECTONIC THERAPEUTIC, INC. Retained Earnings
TECTONIC THERAPEUTIC, INC. (TECX) had Retained Earnings of -$270.26 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-06
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$270.26M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$247.98M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$222.74M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$203.51M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$270.26M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | -$247.98M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | -$222.74M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | -$203.51M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | -$184.48M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | -$164.49M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | -$148.59M 10-K · filed 2026-02-26 | |
| 2024-09-30 | -$136.21M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | -$118.50M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | -$484.08M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | -$90.60M 10-K · filed 2025-03-20 | -$477.27M 10-K · filed 2024-03-14 |
| 2023-09-30 | -$468.49M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | -$446.91M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | -$514.39M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | -$489.43M 10-K · filed 2024-03-14 | |
| 2022-09-30 | -$464.40M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | -$441.43M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | -$413.38M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | -$383.54M 10-K · filed 2023-03-23 | |
| 2021-09-30 | -$355.31M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | -$322.70M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | -$291.31M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | -$264.42M 10-K · filed 2022-03-17 | |
| 2020-09-30 | -$236.28M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | -$199.50M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | -$170.68M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | -$144.70M 10-K · filed 2021-03-18 | |
| 2019-09-30 | -$122.04M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | -$104.90M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | -$88.84M 10-Q · filed 2019-05-13 | |
| 2018-12-31 | -$71.74M 10-K · filed 2020-03-16 | |
| 2018-09-30 | -$55.72M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | -$44.13M 10-Q · filed 2018-08-09 | |
| 2017-12-31 | -$23.47M 10-K · filed 2019-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |